10900sek
0,9 %
Date:2024-07-24Time:17:29:44Latest report:Q2-2024List:First NorthTicker:DVYSR
Market Cap:1 797 msekEnterprise Value:1 661 msekNet Sales:196,0 msekEarnings:-54,2 msekEmployees:0ISIN:SE0016588867

Ratios

10-year key figure history for Devyser Diagnostics turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Devyser Diagnostics with index and moving average MA50 and MA200.

Stockprice:109,00
MA50:107,88
MA200:89,32
Price/MA200:22,0 %
RSI (14):49,7
Price/MA50:1,0 %

Description

Devyser develops, manufactures, and sells kits for genetic testing in routine diagnostics to laboratories in more than 45 countries. The products are used for complex DNA testing in the areas of hereditary diseases, oncology, and post-transplant monitoring to make it possible to diagnose a large number of genetic diseases, target cancer treatment and follow-up transplant patients. Devyser's products simplify complex genetic test procedures, minimize manual elements, and deliver rapid results.

Medical Equipment